Letter/Comment
The latest advocacy letters and comments from the American Hospital Association.
AHA letter to Representative Brad Schneider expressing support for legislation, H.R. 3414, the Opioid Workforce Act of 2019,
AHA urges the Antitrust Division of the Department of Justice (“DOJ”) to investigate thoroughly Centene’s proposed acquisition of WellCare because it threatens to reduce competition in delivery of Medicaid Managed Care and Medicare Advantage (“MA”) services to tens of millions of consumers across…
America’s hospitals and health systems are committed to the goal of affordable, comprehensive health insurance for every American. However, “Medicare for All” is not the solution. Instead, we should build upon and improve our existing system to increase access to coverage and comprehensive health…
AHA letter to Senator Richard J. Durbin expressing support for legislation, S. 551, the Recovering Excessive Funds for Unused and Needless Drugs (REFUND) Act.
AHA comments on the Medicaid and CHIP Payment and Access Commission’s proposed recommendations related to the Medicaid Disproportionate Share Hospital (DSH) program.
AHA comments on the Medicaid and CHIP Payment and Access Commission’s proposed recommendations related to the Medicaid Disproportionate Share Hospital (DSH) program.
The Children’s Hospitals Graduate Medical Education (CHGME) program is a vital investment in strengthening the pediatric workforce and access to care for children. As groups dedicated to protecting and advancing the health of America’s children, we thank you for your longstanding bipartisan support…
Health care is changing rapidly. The rise of consumerism, the digital economy, precision medicine, predictive analytics, artificial intelligence, new high-tech entrants to the health care sector and affordability pressures all serve as catalysts for change. And America’s hospitals and health…
AHA letter to Ways and Means Committee on the Prescription Drug Sunshine, Transparency, Accountability and Reporting Act (H.R. 2113.
A Department of Health and Human Services' Office of Inspector General proposal to change drug discount safe harbors under the federal anti-kickback statute would likely increase premiums for Medicare beneficiaries without addressing the nation's high and rising drug prices, the AHA said.